Viewing Study NCT05763160


Ignite Creation Date: 2025-12-25 @ 2:16 AM
Ignite Modification Date: 2025-12-29 @ 3:02 AM
Study NCT ID: NCT05763160
Status: COMPLETED
Last Update Posted: 2023-11-18
First Post: 2023-02-28
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: An Open-label Study That Will Test a Second Treatment Session of RZL-012.
Sponsor: Raziel Therapeutics Ltd.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2023-05-29
Start Date Type: ACTUAL
Primary Completion Date: 2023-07-30
Primary Completion Date Type: ACTUAL
Completion Date: 2023-10-20
Completion Date Type: ACTUAL
First Submit Date: 2023-02-28
First Submit QC Date: None
Study First Post Date: 2023-03-10
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-11-15
Last Update Post Date: 2023-11-18
Last Update Post Date Type: ACTUAL